Based on our findings, the proportions of anti-tumor immune cells, including CD8+ T cells, CD4+ memory activated T cells, and follicular helper T cells, were significantly increased in the low-risk group compared with the high-risk group. This evidence concerns the gene CD4 and neoplasm.